BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37689970)

  • 1. Asparagine endopeptidase protects podocytes in adriamycin-induced nephropathy by regulating actin dynamics through cleaving transgelin.
    Qiu Y; Lei C; Zeng J; Xie Y; Cao Y; Yuan Q; Su H; Zhang Z; Zhang C
    Mol Ther; 2023 Nov; 31(11):3337-3354. PubMed ID: 37689970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
    Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
    BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
    Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
    J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-206 and its down-regulation of Wilms'Tumor-1 dictate podocyte health in adriamycin-induced nephropathy.
    Guo N; Guo J; Su D
    Ren Fail; 2016 Jul; 38(6):989-95. PubMed ID: 27056206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asparaginyl endopeptidase protects against podocyte injury in diabetic nephropathy through cleaving cofilin-1.
    Lei C; Li M; Qiu Y; Xie Y; Hao Z; Yin X; Zhang Z; Su H; Yang L; Lin J; Hammes HP; Zhang C
    Cell Death Dis; 2022 Feb; 13(2):184. PubMed ID: 35217650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice.
    Liao MC; Miyata KN; Chang SY; Zhao XP; Lo CS; El-Mortada MA; Peng J; Chenier I; Yamashita M; Ingelfinger JR; Chan JSD; Zhang SL
    Clin Sci (Lond); 2022 May; 136(10):715-731. PubMed ID: 35502764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CLEC14A protects against podocyte injury in mice with adriamycin nephropathy.
    Su Z; Li Y; Lv H; Cui X; Liu M; Wang Z; Zhang Y; Zhen J; Tang W; Wang X; Yi F
    FASEB J; 2021 Jul; 35(7):e21711. PubMed ID: 34107098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of necroptosis pathway in podocyte contributes to the pathogenesis of focal segmental glomerular sclerosis.
    Hu H; Li M; Chen B; Guo C; Yang N
    Clin Exp Nephrol; 2022 Nov; 26(11):1055-1066. PubMed ID: 35925422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
    Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
    Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDDO-Me ameliorates podocyte injury through anti-oxidative stress and regulation of actin cytoskeleton in adriamycin nephropathy.
    Xu C; Liu X; Zhai X; Wang G; Qin W; Cheng Z; Chen Z
    Biomed Pharmacother; 2023 Nov; 167():115617. PubMed ID: 37801905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF repairs podocyte damage by microRNA-mediated increase of actin polymerization.
    Li M; Armelloni S; Zennaro C; Wei C; Corbelli A; Ikehata M; Berra S; Giardino L; Mattinzoli D; Watanabe S; Agostoni C; Edefonti A; Reiser J; Messa P; Rastaldi MP
    J Pathol; 2015 Apr; 235(5):731-44. PubMed ID: 25408545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of CD44-positive glomerular parietal epithelial cells reflects podocyte injury in adriamycin nephropathy.
    Okamoto T; Sasaki S; Yamazaki T; Sato Y; Ito H; Ariga T
    Nephron Exp Nephrol; 2013; 124(3-4):11-8. PubMed ID: 24401840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic ablation of SLK exacerbates glomerular injury in adriamycin nephrosis in mice.
    Woychyshyn B; Papillon J; Guillemette J; Navarro-Betancourt JR; Cybulsky AV
    Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1377-F1390. PubMed ID: 32308020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of C/EBP-α in Adriamycin-induced podocyte injury.
    Zhong F; Wang W; Lee K; He JC; Chen N
    Sci Rep; 2016 Sep; 6():33520. PubMed ID: 27644413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis.
    Angeletti A; Cantarelli C; Petrosyan A; Andrighetto S; Budge K; D'Agati VD; Hartzell S; Malvi D; Donadei C; Thurman JM; Galešić-Ljubanović D; He JC; Xiao W; Campbell KN; Wong J; Fischman C; Manrique J; Zaza G; Fiaccadori E; La Manna G; Fribourg M; Leventhal J; Da Sacco S; Perin L; Heeger PS; Cravedi P
    J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32717081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo.
    Wan YG; Che XY; Sun W; Huang YR; Meng XJ; Chen HL; Shi XM; Tu Y; Wu W; Liu YL
    J Ethnopharmacol; 2014 Feb; 151(3):1079-1089. PubMed ID: 24362077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice with mutant Inf2 show impaired podocyte and slit diaphragm integrity in response to protamine-induced kidney injury.
    Subramanian B; Sun H; Yan P; Charoonratana VT; Higgs HN; Wang F; Lai KV; Valenzuela DM; Brown EJ; Schlöndorff JS; Pollak MR
    Kidney Int; 2016 Aug; 90(2):363-372. PubMed ID: 27350175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD147/Basigin Deficiency Prevents the Development of Podocyte Injury through FAK Signaling.
    Yoshioka T; Kosugi T; Masuda T; Watanabe T; Ryuge A; Nagaya H; Maeda K; Sato Y; Katsuno T; Kato N; Ishimoto T; Yuzawa Y; Maruyama S; Kadomatsu K
    Am J Pathol; 2019 Jul; 189(7):1338-1350. PubMed ID: 31014956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
    Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
    J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAD2B-mediated cell cycle reentry of podocytes is involved in the pathogenesis of FSGS.
    Bao D; Su H; Lei CT; Tang H; Ye C; Xiong W; He FF; Lin JH; Hammes HP; Zhang C
    Int J Biol Sci; 2021; 17(15):4396-4408. PubMed ID: 34803506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.